Skip to main content
MM

Meddai Medical

Meddai Medical develops the MeddAI InstaScan, a portable breast cancer screening device that utilizes MIMO sensor technology to deliver precise diagnostics with a 99% accuracy rate. By leveraging a dataset of over a billion data points, the company enhances early cancer detection, improving treatment planning and patient outcomes.

St. John's, CanadaFounded 20221300+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional breast cancer screening methods can be uncomfortable, time-consuming, and may lack the precision needed for early and accurate detection, leading to delayed diagnoses and potentially poorer patient outcomes. Current screening technologies may also be less accessible in remote areas or require specialized facilities, limiting widespread use.

Solution

Meddai Medical has developed the MeddAI InstaScan, a portable breast cancer screening device that utilizes MIMO (multiple-input multiple-output) sensor technology to provide precise and comfortable diagnostics. The device is designed for ease of use, enabling routine screenings without the discomfort associated with traditional methods. MeddAI InstaScan generates detailed reports, facilitating timely and effective medical responses. The company leverages a large dataset and advanced algorithms to enhance the accuracy and efficiency of cancer screening, aiming to improve early detection and treatment planning.

Target Audience

The primary target audience includes healthcare providers, hospitals, and clinics seeking to improve the accuracy, accessibility, and efficiency of breast cancer screening, as well as patients who desire a more comfortable and convenient screening experience.

Features

  • Portable design for convenient and accessible breast cancer screening.
  • MIMO sensor technology for precise imaging and analysis of breast tissue.
  • AI-powered algorithms trained on a dataset of over a billion data points for enhanced accuracy.
  • User-friendly interface for comfortable and routine screenings.
  • Detailed reports on detected cancer types to facilitate timely medical responses.
  • API integration for seamless incorporation into existing healthcare systems.
  • Adherence to data privacy regulations, including GDPR and HIPAA, with robust encryption and security protocols.
  • Optional Raspberry Pi scanning option for on-premises screening.
This profile is AI-generated and may contain inaccuracies.